The NASDAQ filing is available at the links below. If I interpret correctly CBD is not nominating an issue price or number of shares but is nominating how much the IPO would raise (about $13,800,000 of which about $2M goes in listing costs). A (potentially) big chunk of the remainder goes to buying an existing USA company as a footprint in the US and more goes to keeping existing creditors paid on time.
Presumably the issue price will be made known when the market has assessed the offer and bid on it. No time line is given.
